Nautilus Biotechnology, Inc.
NAUT

$
Marketcap
$0.00
Share price
Country
N/A
Change (1 day)
N/A
Year High
N/A
Year Low
Categories

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

etoro